FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

768883004: Biphasic isophane insulin human (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3687359018 Biphasic isophane insulin human (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3687360011 Biphasic isophane insulin human en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Biphasic isophane insulin human This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) false Inferred relationship Some
    Biphasic isophane insulin human Is a Human insulin false Inferred relationship Some
    Biphasic isophane insulin human Is a bifasisk isophaninsulin false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1
    bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Product containing biphasic isophane insulin human in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1
    bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some
    Product containing only biphasic isophane insulin human (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1
    Product containing only biphasic isophane insulin human in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Biphasic isophane insulin human Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start